Valneva to start final vaccine trials with new shot in virus arsenal
The vaccine uses the whole, inactivated virus to create an immune response, an old but proven approach
06 April 2021 - 12:59
London — Valneva plans to start final-phase trials on its Covid-19 vaccine candidate in APril after positive early-stage studies, a step forward for an old-school shot that’s backed by the UK government.
The French company said on Tuesday that a phase 1/2 test produced significant levels of antibodies in more than 90% of participants and raised no safety concerns. Valneva shares rose as much as 8.4% in Paris trading...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.